Tricuspid Valve Insufficiency clinical trials in California
14 active Tricuspid Valve Insufficiency trials with a site in California. Describe your situation to see which ones look like a fit.
- TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
- Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- Clinical Study of the inQB8 TTVR System
- TTVR Early Feasibility Study
- EFS of the DUO System for Tricuspid Regurgitation
- Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
- Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
- Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
- A Post-Market Assessment of the Safety and Performance of the TriClip™ System
- TriClip CED RWE Study
- TTVR STRONG Under Coverage With Evidence Development (CED) Study
- Trisol System EFS Study
- Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
- Pivotal Trial to Evaluate the Safety and Effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.